Skip to search formSkip to main contentSkip to account menu

FluMist

Known as: CAIV-T vaccine 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Influenza virus vaccinetrivalent influenza vaccine
Trivalent Live Attenuated Influenza Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
1954. A Randomized Study to Evaluate the Shedding and Immunogenicity of H1N1 Strains in Trivalent and Quadrivalent Formulations of FluMist in Children 24 to <48 Months of Age
Abstract Background The quadrivalent live attenuated influenza vaccine (LAIV4) showed reduced effectiveness for the A/H1N1… 
Review
2013
Review
2013
Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators
Abstract Context: Fluzone Intradermal (ID) vaccine was licensed in the United States in May 2011 and uses a microinjection device… 
Highly Cited
2011
Highly Cited
2011
Transport Activity of the High-affinity Monocarboxylate Transporter MCT2 Is Enhanced by Extracellular Carbonic Anhydrase IV but Not by Intracellular Carbonic Anhydrase II*
The ubiquitous enzyme carbonic anhydrase isoform II (CAII) has been shown to enhance transport activity of the proton-coupled… 
2011
2011
FluMist vaccine: Questions and answers - summary.
FluMist (AstraZeneca Canada Inc) is a live attenuated vaccine for intranasal administration that has recently been licensed in… 
2008
2008
Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype.
2006
2006
Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process.
Review
2002
Review
2002
Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children.
The trivalent, cold-adapted influenza vaccine (CAIV-T, FluMist, Aviron, Mountain View, CA) is a live attenuated influenza virus… 
2001
2001
Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
Studies in children and adults revealed cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine (CAIV-T) to be… 
2001
2001
Efficacy and effectiveness of attenuated, cold-adapted, trivalent intranasal influenza vaccine
Review
2000
Review
2000
Technology evaluation: FluMist, University of Michigan.
  • A. Billich
  • Current opinion in molecular therapeutics (Print)
  • 2000
  • Corpus ID: 42869680
FluMist is an intranasal influenza vaccine, which has been developed by Aviron. The genetically engineered, live, attenuated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)